跳至主要内容
临床试验/CTRI/2023/07/055888
CTRI/2023/07/055888招募中Unknown

Efficacy of High Dose Albumin Therapy in Improving Liver Transplant-free Survival in Patients With Acute Decompensation of Cirrhosis- A Prospective Cohort Study - NI

Takeda Pharmaceuticals0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Patients with acute decompensation of cirrhosis
  • 2.Patients with age from 18-65 years

排除标准

  • 1.Recent Gastrointestinal bleeding within 7 days
  • 2.Patients with organic nephropathy (as defined by IAC)
  • 3.Patients with Cardiovascular disease or chronic obstructive pulmonary disease
  • 4.Systemic arterial hypertension ( >160/90mmhg)
  • 5.Presence of hepatocellular carcinoma (outside Milan criteria) ( or portal vein thrombosis
  • 6.Budd-Chiari Syndrome
  • 7.Pregnancy
  • 8.Patients with serum albumin >3 gm
  • 9.Refusal to participate
  • 10.Known or suspected hypersensitivity to albumin
  • 11.Prior TIPS
  • 12.Post liver or kidney transplantation
  • 13.Patients enrolled in other clinical trials
  • 14.Extrahepatic malignancy.

研究者

发起方
Takeda Pharmaceuticals

相似试验